RecallDepth
Class III Terminated

Fenofibric Acid, immediate release tablet, 105 mg, a) 30 count bottle (NDC 53489-678-07), b) 90 count bottle (NDC 53489-678-90), Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA

Company
Mutual Pharmaceutical Company, Inc.
Recall Initiated
February 27, 2013
Posted
January 15, 2014
Recall Number
D-400-2014
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Philadelphia, PA, United States

Reason for Recall

Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated." The labeling for the recalled lots

Distribution

Nationwide and Puerto Rico.

Lot / Code Info

lot 6581105 & 6581106 exp. 07/15, and lot 6623001 & 6623002 exp. 01/16

More recalls by Mutual Pharmaceutical Company, Inc.

View all recalls by this company →

Other recent Class III Drug recalls